Abstract:Pulmonary surfactant (PS), a complex mixture of lipids and proteins, is essential for maintaining proper lung function. It reduces surface tension in the alveoli, preventing collapse during expiration and facilitating re-expansion during inspiration. Additionally, PS has crucial roles in the respiratory system's innate defense and immune regulation. Dysfunction of PS contributes to various respiratory diseases, including neonatal respiratory distress syndrome (NRDS), adult respiratory distress syndrome (ARDS), COVID-19-associated ARDS, and ventilator-induced lung injury (VILI), among others. Furthermore, PS alterations play a significant role in chronic lung diseases such as chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF). The intracellular stage involves storing and releasing a specialized subcellular organelle known as lamellar bodies (LB). The maturation of these organelles requires coordinated signaling to organize their intracellular organization in time and space. LB's intracellular maturation involves the lipid composition and critical processing of surfactant proteins to achieve proper functionality. Over a decade ago, the supramolecular organization of lamellar bodies was studied using electron microscopy. In recent years, novel bioimaging tools combining spectroscopy and microscopy have been utilized to investigate the in cellulo intracellular organization of lamellar bodies temporally and spatially. This short review provides an up-to-date understanding of intracellular LBs. Hyperspectral imaging and phasor analysis have allowed identifying specific transitions in LB's hydration, providing insights into their membrane dynamics and structure. A discussion and overview of the latest approaches that have contributed to a new comprehension of the trafficking and structure of lamellar bodies is presented.

Revealing the Pulmonary Surfactant Corona on Silica Nano-particles by Cryo-Transmission Electron Microscopy

Computational Investigations of the Interaction Between the Cell Membrane and Nanoparticles Coated with a Pulmonary Surfactant.

Lipidomic Analysis Probes Lipid Coronas on Hydrophilic Nanoparticles from Natural Lung Surfactant

Supported pulmonary surfactant bilayers on silica nanoparticles: Formulation, stability and impact on lung epithelial cells

Biophysicochemical interaction of a clinical pulmonary surfactant with nano-alumina

Sol-gel transition induced by alumina nanoparticles in a model pulmonary surfactant

Pulmonary surfactant inhibition of nanoparticle uptake by alveolar epithelial cells

The role of surface charge in the interaction of nanoparticles with model pulmonary surfactants

Study Interactions Between Inhaled Nanoparticles and Pulmonary Surfactant Using Molecular Dynamics Simulations

Effect of Nanoparticles on the Bulk Shear Viscosity of a Lung Surfactant Fluid

Lipid extraction mediates aggregation of carbon nanospheres in pulmonary surfactant monolayers.

Nanoparticle Translocation Across the Lung Surfactant Film Regulated by Grafting Polymers.

Protein corona: implications for nanoparticle interactions with pulmonary cells

Novel opportunities from bioimaging to understand the trafficking and maturation of intracellular pulmonary surfactant and its role in lung diseases

Alteration of biophysical activity of pulmonary surfactant by aluminosilicate nanoparticles

Biophysical influence of airborne carbon nanomaterials on natural pulmonary surfactant

Nanoscale characterization of the biomolecular corona by cryo-electron microscopy, cryo-electron tomography, and image simulation

Transport Of Nanoparticles Across Pulmonary Surfactant Monolayer: A Molecular Dynamics Study

Comment on Bilayer aggregate microstructure determines viscoelasticity of lung surfactant suspensions by C.O. Ciutara and J.A. Zasadzinski, Soft Matter, 2021, 17, 5170-5182

A Simulation Study on the Interaction Between Pollutant Nanoparticles and the Pulmonary Surfactant Monolayer

Dual role of pulmonary surfactant corona in modulating carbon nanotube toxicity and benzo[a]pyrene bioaccessibility